PHARMAFOCUS 2026 UPDATE
November 2022Gerry Jeffcott, Bill Dempster, Don Sancton, Michel Parent, Stephanie Levee | IQVIA
2022
Profiles in reimbursement – The important and ever-evolving role of CADTH
May 2022Gerry Jeffcott and Don Sancton | Provincial Reimbursement Advisor
PHARMAFOCUS 2026
June 2022Gerry Jeffcott, Bill Dempster, Don Sancton, Michel Parent, Stephanie Levee | IQVIA
Profiles in reimbursement – The important and ever-evolving role of the pCPA
November 2022Gerry Jeffcott | Provincial Reimbursement Advisor
The road to national pharmacare in Canada: Where will the federal NDP-Liberal agreement take us?
August 2022Don Sancton | Provincial Reimbursement Advisor
Oh national rare disease treatment strategy, wherefore art thou?
August 2022Gerry Jeffcott | Provincial Reimbursement Advisor
Is Canada spending what it should on medications?
February 2022Gerry Jeffcott | Provincial Reimbursement Advisor
The Pathway for New Cancer Drug Access in Canada
January 2022Johanne Chambers, William Dempster, Joanna Gotfrit, Paul Whealtey-Price | Current Oncology Vol. 29(2)
PHARMAFOCUS 2022 UPDATE
November 2018Gerry Jeffcott, Bill Dempster, Michel Parent, Rachael Manion | IQVIA